Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
231.50
+4.00 (+1.76%)
Official Closing Price
Updated: 7:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,252,483
Open
228.42
Bid (Size)
228.68 (100)
Ask (Size)
232.30 (100)
Prev. Close
227.50
Today's Range
228.00 - 234.74
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.99%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
8 Cheap Stocks to Buy in 2026
↗
Today 9:45 EST
All 8 stocks with big upside
Via
The Motley Fool
1 No-Brainer Dividend Stock to Buy on the Dip
↗
February 15, 2026
The recent dip may have been an overreaction.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
+1.0%
+1.0%
1 Month
+8.0%
+8.0%
3 Month
-1.1%
-1.1%
6 Month
+12.1%
+12.1%
1 Year
+18.0%
+18.0%
More News
Read More
5 Best Stocks to Buy in February
↗
February 15, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
3 Dividend Stocks to Hold for the Next 20 Years
↗
February 15, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Inc. (NYSE:ABBV) Raises 2026 Outlook Despite Q4 Revenue Miss
↗
February 04, 2026
Via
Chartmill
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
↗
February 14, 2026
Via
The Motley Fool
Topics
Stocks
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
↗
February 14, 2026
Via
The Motley Fool
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Government
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
1 Reason I'm Never Selling AbbVie Stock
↗
February 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
February 11, 2026
Via
Finterra
Topics
Economy
Intellectual Property
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call
February 11, 2026
Via
StockStory
Topics
Earnings
Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year
↗
February 10, 2026
Via
The Motley Fool
Topics
ETFs
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
Via
FinancialNewsMedia
3 Market-Beating Stocks to Research Further
February 08, 2026
Via
StockStory
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
↗
February 05, 2026
Via
MarketBeat
ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds
February 05, 2026
Via
StockStory
AbbVie (ABBV) Q4 2025 Earnings Call Transcript
↗
February 04, 2026
Via
The Motley Fool
Topics
Earnings
Gapping S&P500 stocks in Wednesday's session
↗
February 04, 2026
Via
Chartmill
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
February 04, 2026
Via
Chartmill
AbbVie’s (NYSE:ABBV) Q4 CY2025: Beats On Revenue
February 04, 2026
Via
StockStory
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
↗
February 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie (ABBV) Q4 Earnings: What To Expect
February 02, 2026
Via
StockStory
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via
MarketMinute
Topics
ETFs
Government
Initial Public Offering
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 231.50
When was AbbVie last traded?
The last trade of AbbVie was at 02/13/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today